BiovaxID Articles

FDA calls for Biovest to conduct another Ph III trial of BiovaxID in NHL

16 August 2012

Biovest to file for EU approval of BiovaxID, a personalized cancer vaccine

16 May 2012

Cancer vaccines poised to reach $3 billion in sales by 2015

20 April 2011

Biovest sees mantle cell lymphoma as next target indication for personalized cancer vaccine

25 June 2010

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end